Patient Registry Software Market

The global patient registry software market is projected to grow from USD 2.47 billion in 2026 to USD 3.99 billion by 2031, at a CAGR of 10.0% during the forecast period. The rising burden of chronic and rare diseases, increasing demand for real-world evidence, and growing emphasis on tracking patient outcomes are supporting market growth. Patient registries help healthcare providers, pharmaceutical companies, research organizations, and public health agencies collect and manage longitudinal patient data for disease monitoring, clinical research, treatment evaluation, and quality improvement. The growing use of electronic health records and interoperable digital health platforms is pushing organizations to shift from fragmented data collection to more connected registry workflows. In addition, cloud-based platforms and AI-enabled tools are improving data abstraction, patient identification, and outcomes analysis, supporting more efficient and data-driven healthcare and research activities.

The prominent players operating in the patient registry software market include IBM (US), IQVIA (US), Health Catalyst (US), Oracle (US), Optum, Inc. (US), Conduent Incorporated (US), Elekta (Sweden), Medidata (Dassault Systèmes) (France), and Dacima Software, Inc. (EvidentIQ) (Germany), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, and mergers & acquisitions to strengthen their presence in the patient registry software market.

To know about the assumptions considered for the study download the pdf brochure

In September 2026, Oracle enhanced Oracle Life Sciences Data Intelligence by combining real-world data, domain-trained AI, and advanced analytics within a connected platform. The platform lets pharmaceutical research teams explore patient cohorts with natural-language queries, analyze outcomes, and automate research workflows using Oracle Health Real-World Data, which includes more than 122 million de-identified patient records.

In March 2026, Medidata partnered with CRIO to expand integration between clinical site eSource solutions and clinical trial data management. The collaboration supports more than 2,500 research sites across approximately 30 countries, helping connect site-level clinical data with broader research workflows.

IBM

IBM (US) provides enterprise data management capabilities that support patient identity resolution, data integration, and the consolidation of healthcare information. Its InfoSphere MDM for Patient solution includes capabilities to maintain consistent patient records across healthcare systems, while the Advanced Edition supports patient registries and health information exchange environments. These capabilities help organizations address duplicate records, improve data quality, and establish a more reliable view of patient information. IBM's master data management and data governance technologies also support population health analytics and longitudinal patient data management, making them relevant to the infrastructure healthcare organizations use to maintain and exchange registry data.

IQVIA

IQVIA (US) provides healthcare data, technology, and clinical research services, including dedicated patient registry solutions. Its Clinical Insight Registry Platform enables the collection of disease-specific, research-ready real-world data through patient-reported information, clinician-reported information, or a combination of both. The platform supports longitudinal data collection, clinical trial recruitment, quality improvement, and research, with configurable workflows, audit trails, access controls, dashboards, and data visualization capabilities. It can also integrate with external data sources using formats and standards such as HL7 and CDISC. These capabilities help pharmaceutical companies, healthcare providers, medical societies, and research organizations manage patient information and generate evidence to support clinical research, treatment evaluation, and patient outcome monitoring.

Health Catalyst

Health Catalyst (US) provides healthcare data and analytics solutions, including clinical registry technology through its ARMUS portfolio. Its ARMUS for Hospitals Clinical Registry Suite supports registry development, data abstraction, automated data collection, data quality management, and registry submissions. Related offerings, including ARMUS HYBRID Outcomes and ARMUS HYBRID Analytics, support patient-centric registry data management, validation, longitudinal reporting, benchmarking, and comparisons across hospitals and clinicians. Integration with electronic medical records helps reduce manual data-entry efforts and improve data consistency. These capabilities help hospitals, medical societies, and quality collaboratives streamline registry participation, assess clinical performance, and use patient outcome data to support quality improvement and clinical research.

MARKET RANKING

The global patient registry software market comprises established healthcare technology companies, clinical research and data analytics providers, and specialized registry solution vendors. IBM, IQVIA, Health Catalyst, Oracle, and Optum, Inc. are leading players, supported by capabilities in healthcare data management, clinical research, analytics, and patient information integration. IQVIA offers dedicated patient registry solutions, while Health Catalyst provides clinical registry technology through its ARMUS portfolio. IBM supports patient identity management and registry-related data infrastructure, whereas Oracle and Optum contribute through healthcare data platforms, real-world data analytics, and population health capabilities. Conduent Incorporated, Elekta, and Medidata (Dassault Systèmes) further participate through public health surveillance, cancer registry management, and clinical research data solutions.

Other participants, including Dacima Software, Inc. (EvidentIQ), FIGmd, Inc. (MRO Corporation), ImageTrend, Global Vision Technologies, Inc., Syneos Health, Veradigm LLC, ESO, Ordinal Data, Inc., NEC Software Solutions UK Limited, Cedaron Medical, Fivos Health, and Across Healthcare, contribute through specialized clinical, disease-specific, trauma, and healthcare data management solutions. Verana Health, Pulse Infoframe, Inc., Amplitude Clinical Outcomes, nPhase, Inc., and OM1 also contribute through real-world evidence generation, patient outcomes tracking, disease-specific data platforms, and clinical research support. Competition across the market is shaped by registry functionality, data quality, interoperability, analytics capabilities, therapeutic-area expertise, and the ability to support longitudinal patient monitoring, research, and regulatory reporting.

Related Reports:

Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [Profit (Pharma, Payer, Hospital), Non-profit (Govt)], and Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]